USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
GLC BIOTECHNOLOGY, INC.
Address:
GLC BIOTECHNOLOGY, INC.
7362 STOCKWOOD DRIVE
SOLON, OH 44139
Phone:
N/A
URL:
N/A
EIN:
300091007
DUNS:
144259343
Number of Employees:
N/A
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
Yes

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $464,350.00 3
SBIR Phase II $3,142,256.00 2

Award List:

Molecular Haplotyping of Long Genomic Distances of DNA

Award Year / Program / Phase:
2004 / SBIR / Phase I
Award Amount:
$100,000.00
Agency:
HHS
Principal Investigator:
Abstract:
This SBIR project is proposed to commercialize a novel method referred as PDESA for revealing patient's individual haplotypes. Our preliminary data shown that PDESA could reveal haplotypes of sequences of 134kb in length, which is about three times longer than the longest sequence haplotyped using… More

Surveying the Status of a Large Number of Mutations by A Single PEPD Assay

Award Year / Program / Phase:
2006 / SBIR / Phase II
Award Amount:
$1,342,961.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): This application is to develop the PEPD technology to survey the mutation status of hundreds of DMA markers in a vast excess of wild-type DNA for cancer screening. Specifically, we will develop a fecal DMA testing assay for colorectal cancer (CRC) screening.… More

A Novel Technology for Capturing Fecal HUMAN DNA

Award Year / Program / Phase:
2006 / SBIR / Phase I
Award Amount:
$145,000.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): This project focuses on the development of a robust and efficient method to isolate human DNA from stool for fecal DNA screening of colorectal cancer (CRC). CRC is the second deadest cancer in USA and early detection is the key to eradication of this disease.… More

MMPA: A Novel Multiplexing Methylation Analysis Technology

Award Year / Program / Phase:
2008 / SBIR / Phase I
Award Amount:
$219,350.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): This fast-track SBIR project is to develop a novel multiplexed methylation profiling assay (MMPA) technology for methylation analysis of DNA derived from clinical specimens. Specifically, we will develop the MMPA assays (one for each type of cancer) for analysis… More

MMPA: A Novel Multiplexing Methylation Analysis Technology

Award Year / Program / Phase:
2009 / SBIR / Phase II
Award Amount:
$1,799,295.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): This fast-track SBIR project is to develop a novel multiplexed methylation profiling assay (MMPA) technology for methylation analysis of DNA derived from clinical specimens. Specifically, we will develop the MMPA assays (one for each type of cancer) for analysis… More